Summary Neoplastic tissue was obtained at operation from 10 renal cell carcinomas, from the adjacent 'normal' kidney in 6 cases and from 1 other normal kidney. The biopsies were snap frozen in liquid nitrogen and sections were subsequently stained with monoclonal antibodies against major histocompatibility complex (MHC) antigens, class I and II, and several types of mononuclear cell, by the indirect immunoperoxidase method. The degree of staining or the number of cells stained was estimated as heavy 4, through moderate 3, few 2, occasional 1, or nil 0. MHC Ag were consistently expressed, grade 2-4, by the glomeruli and proximal convoluted tubules of normal kidney, but were absent in 8 of 10 carcinomas. There was a grade 3-4 mononuclear cell infiltration in the stroma of normal kidney and between the carcinoma cells which was composed principally of macrophages. However in the two carcinomas expressing MHC Ag there was also a grade 2-3 infiltration with T lymphocytes. The absence of MHC Ag on carcinoma cells mitigates against attempts to potentiate the patient's immune response to his tumour, e.g. by renal artery embolisation.
Renal cell carcinomas account for 3% of all malignant neoplasms and have an incidence of 4 per 100,000 persons (Kantor, 1977) . Whilst the 5 year survival rate following radical nephrectomy was 62% in patients without metastases, this fell to 13% for patients with metastases (Nurmi, 1984) . Furthermore approximately 30% of patients have metastases at the time of their initial diagnosis (Middleton, 1967) .
The marked difference in prognosis depending on the presence of metastases, together with the occurrence of spontaneous remission in 1 of 200 patients with metastases (Holland, 1973) , have led to suggestions that an immune response by the patient to the tumour may be important in determining the clinical outcome (Woodruff, 1980) . In an attempt to potentiate this renal artery embolisation prior to nephrectomy has been employed, but the majority of reports show no benefit from this procedure (Kaisary et al., 1984) . It therefore seemed germane to study the expression of major histocompatibility complex (MHC) antigens by renal cell carcinoma cells and the degree and nature of the mononuclear cell infiltrate in this neoplasm. To this end staining with monoclonal antibodies reactive with the appropriate antigens has been employed. The mononuclear cell infiltrates and histocompatibility antigen expression were compared between neoplastic tissue and an adjacent area of 'normal' tissue from the tumour bearing kidney. Similar techniques have been used to monitor the expression of MHC Ag in neoplastic cells and to identify lymphocyte subsets among mononuclear cells infiltrating melanomas (Kornstein et al., 1983) and breast (Bahn & Des \4aris, 1983; Whitwell et al., 1984) , ovarian (Kabawat et al., 1983) and colorectal (Umpleby et al., 1985) carcinomas.
Materials and methods
A 0.5 g specimen was obtained from the tumour in 10 patients, and in 6 of these a similar biopsy was obtained from the apparently normal adjacent kidney tissue. One further area of unaffected kidney was biopsied without a specimen of the appropriate tumour being obtained.
Histologic sections
The freezing, section cutting and indirect immunoperoxidase staining techniques employed were as previously described (Umpleby et al., 1985) .
Monoclonal antibodies
MoAb HLe-I anti-PBL and anti-thymocyte, UCHT-l anti-T3, UCHT-4 anti-T8 and MASO17 anti-HLA-A, B, C have previously been described (Umpleby et al., 1985 (Table I) .
Discussion
In normal kidneys HLA-ABC Ag were expressed on the glomeruli and intertubular capillaries whilst the tubules showed intracellular staining (Fuggle et al., 1983) . HLA-DR Ag was also consistently present on the glomeruli and intertubular capillaries. However, in the proximal tubules expression was variable. Among 46 kidneys there were 27 positive, 1-1 negative and 8 weakly positive. Staining with the MoAb was intracellular extending throughout the cytoplasm. Renal cell carcinomas arise from the epithelial cells lining the proximal convoluted tubules (Borowitz et al., 1986) . Thus failure to express these antigens by the carcinoma cells from those kidneys where the 'normal remnant' showed positive staining would imply their loss during the process of neoplastic transformation. In one patient (no. 3) where this was not so, the degree of class I MHC expression was heterogeneous. Natali et al. (1984) reported the expression of class I MHC Ag, in 9 of 10 renal cell carcinomas. However only in I of these tumours did the staining by anti HLA-ABC Ab have a cytoplasmic distribution similar to that of normal proximal tubules. Natali et al. (1984) reported the expression of HLA-ABC Ag in tumours to be dependent on the MoAb used. Thus the ability of MAS-017 and M704, in the present study, to detect class I and II MHC Ag in 'normal kidney' but not on the appropriate tumour cells is critical in sustaining the hypotheses of Ag loss on malignant transformation.
In keeping with the poor expression of MHC antigens by the carcinoma cells, there was little infiltration of the tumour by cells of the T lymphocyte series. This may be contrasted with the findings for other tumours, cited above. The exceptions were patients 3 and 9 in whom the tumour cells expressed MHC antigens in varying degrees. The favourable outcome (Table I) in patient 3, despite the degree of initial tumour spread, is of interest in this context. The recognition of any tumour associated antigens by cytotoxic T lymphocytes of the host occurs in association with recognition of self MHC Ag (Meuer et al., 1982; Wallace et al., 1982) . Thus failure to express MHC would preclude an immune response (mediated by this effector cell population) of the patient to the tumour. This in turn would mitigate against the efficacy of renal artery embolisation, which produces in situ tumour necrosis in inducing such a response. Indeed it has been reported that there is a decrease in the helper T lymphocyte subset in the blood of patients with renal cell carcinoma, a defect which significantly improved one week after nephrectomy alone, but not when pre-operative embolisation was also performed (Ritchie et al., 1984) . In an animal model a relationship was found between abnormalities in the expression of MHC Ag and metastatic spread (De Baetseiler et al., 1980) . It must be emphasised, that other classes of anti-tumour effector cell, specifically natural killer cells, lymphokine activated killer cells and macrophages do not require concomitant recognition of MHC antigens to be effective. The majority of tumours indeed, showed a marked infiltration with macrophages. They could be scavengers responding to the presence of necrotic tissue. However, there was no correlation between macroscopic evidence of tumour necrosis and macrophage infiltration (Tables I and IV) .
The findings of the present experiments suggest two approaches to immunotherapy for renal cell carcinoma. First to induce the expression of MHC Ag by the carcinoma cells and second to increase the degree of macrophage infiltration of the tumour.
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